---
title: "Zhong Yuan Bio-Technology Holdings Limited (ZHYBF.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ZHYBF.US/norm.md"
symbol: "ZHYBF.US"
name: "Zhong Yuan Bio-Technology Holdings Limited"
parent: "https://longbridge.com/en/quote/ZHYBF.US.md"
datetime: "2026-03-14T11:46:15.915Z"
locales:
  - [en](https://longbridge.com/en/quote/ZHYBF.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ZHYBF.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ZHYBF.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/ZHYBF.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ZHYBF.US/norm.md)


# Zhong Yuan Bio-Technology Holdings Limited (ZHYBF.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0042 | -0.0042 | 0.0029 | 0.0221 | -0.0190 |
| ROE | 144.00% | -1211.07% | 108.67% | -1446.59% | 192.08% |
| Revenue | 348878.00 | 348878.00 | 482013.00 | 1.10M | 456692.00 |
| Net income | -73639.00 | -73639.00 | 51577.00 | 397910.00 | -335609.00 |
| Operating income | -111893.00 | -111893.00 | 92306.00 | 398037.00 | -585134.00 |
| Gross margin | 117.08% | 117.08% | 46.70% | 93.75% | 96.97% |
| Net margin | -21.11% | -21.11% | 10.70% | 36.22% | -73.49% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
| --- | --- | --- | --- | --- | --- |
| A&L | 3.17M | 3.17M | 3.22M | 3.17M | 2.13M |
| Leverage | -14.48 | -14.48 | 12.93 | 21.61 | -3.13 |
| BVPS | -0.0116 | -0.0116 | 0.0143 | 0.0072 | -0.0395 |
| Turnover | 0.8594 | - | 0.8583 | - | 0.6668 |
| Cash & STI | 145257.00 | 145257.00 | 76618.00 | 42653.00 | 277836.00 |
| Inv & Rec | 29659.00 | 29659.00 | 86070.00 | 101069.00 | 131474.00 |
| LT assets | 580060.00 | 580060.00 | 636237.00 | 674549.00 | 528291.00 |
| Net debt | 2.48M | 2.48M | 2.23M | 2.34M | 1.77M |

## Cash Flow Statement (USD)

| Indicator | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | - | - | - | - | - |
| Investing CF | - | - | - | - | - |
| Financing CF | - | - | - | - | - |
| Free CF | - | - | - | - | - |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |